Inventor · disambiguated record
Jan Terje Andersen
Also filed as: ANDERSEN JAN TERJE
10 granted patents·28 pending applications·92 citations·filing 2010–2024
89Inventor score
Top patents by PatentIndex Score
38 records- 0195US8748380B2Albumin variantsPLUMRIDGE ANDREW·Filed 2010·Granted Jun 10, 2014·33 cites·20 claims
- 0291US10696732B2Albumin variantsALBUMEDIX LTD·Filed 2018·Granted Jun 30, 2020·3 cites·8 claims
- 0391US10501524B2Albumin variantsALBUMEDIX LTD·Filed 2015·Granted Dec 10, 2019·6 cites·25 claims
- 0489US8822417B2Albumin variantsANDERSEN JAN TERJE·Filed 2012·Granted Sep 2, 2014·27 cites·15 claims
- 0588US10934341B2Albumin variantsALBUMEDIX LTD·Filed 2019·Granted Mar 2, 2021·3 cites·28 claims
- 0684US11319383B2Engineered immunoglobulins with altered FcRn bindingUNIV | OSLO·Filed 2017·Granted May 3, 2022·3 cites·7 claims
- 0784US10233228B2Albumin derivatives and variantsPLUMRIDGE ANDREW·Filed 2011·Granted Mar 19, 2019·10 cites·18 claims
- 0881US10208102B2Albumin variants and uses thereofUNIV OSLO·Filed 2014·Granted Feb 19, 2019·6 cites·12 claims
- 0975US2020385442A1Albumin variantsALBUMEDIX LTD·Filed 2020·Application pending·0 cites
- 1073US10781245B2Albumin variants and uses thereofUNIV OSLO·Filed 2019·Granted Sep 22, 2020·1 cites·8 claims
- 1172US2018105576A1Albumin variantsALBUMEDIX AS·Filed 2017·Application pending·0 cites
- 1272US2024343793A1Antibody variantsTILLOTTS PHARMA AG·Filed 2024·Application pending·0 cites
- 1370US2018222963A1Albumin variantsALBUMEDIX AS·Filed 2018·Application pending·0 cites
- 1470US2018162925A1Albumin variantsALBUMEDIX AS·Filed 2018·Application pending·0 cites
- 1570US2014234311A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2014·Application pending·0 cites
- 1669US2018105578A1Albumin variantsALBUMEDIX AS·Filed 2017·Application pending·0 cites
- 1769US2018072792A1Albumin variantsALBUMEDIX AS·Filed 2017·Application pending·0 cites
- 1869US2018105577A1Albumin variantsALBUMEDIX AS·Filed 2017·Application pending·0 cites
- 1964US2016075757A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2015·Application pending·0 cites
- 2064US2016075759A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2015·Application pending·0 cites
- 2164US2016009787A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2015·Application pending·0 cites
- 2264US2016075756A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2015·Application pending·0 cites
- 2364US2022348690A1Engineered immunoglobulins with altered fcrn bindingUNIV | OSLO·Filed 2022·Application pending·0 cites
- 2464US2016075760A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2015·Application pending·0 cites
- 2564US2016075763A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2015·Application pending·0 cites
- 2664US2016075762A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2015·Application pending·0 cites
- 2763US2014128326A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2013·Application pending·0 cites
- 2863US2020102368A1Albumin variantsALBUMEDIX LTD·Filed 2019·Application pending·0 cites
- 2962US2016075758A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2015·Application pending·0 cites
- 3062US2016075761A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2015·Application pending·0 cites
- 3161US2019113519A1Pharmacokinetic animal modelALBUMEDIX LTD·Filed 2018·Application pending·0 cites
- 3260US11999781B2Antibody variantsTILLOTTS PHARMA AG·Filed 2018·Granted Jun 4, 2024·0 cites·5 claims
- 3357US2016033523A1Pharmacokinetic animal modelNOVOZYMES BIOPHARMA DK AS·Filed 2014·Application pending·0 cites
- 3457US2025002602A1Iga fc and igg fc tandem protein constructsUNIV OSLO HF·Filed 2022·Application pending·0 cites
- 3554US2014315816A1Albumin variantsNOVOZYMES BIOPHARMA DK AS·Filed 2014·Application pending·0 cites
- 3647US2025333531A1Humanized hh1NORDIC NANOVECTOR ASA·Filed 2022·Application pending·0 cites
- 3744US2013225496A1Albumin VariantsPLUMRIDGE ANDREW·Filed 2011·Application pending·0 cites
- 3835US2019201496A1Blockade of alphafetoprotein (afp) interactions with beta2-microglobulin associated moleculesBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jan Terje Andersen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →